TELO Stock Summary and Trading Ideas (Telomir Pharmaceuticals | NASDAQ:TELO)

Telomir Pharmaceuticals Inc is a pioneering preclinical-stage pharmaceutical company which leads the advancement of age-reversal science. The Company is focused on developing Telomir-1, a novel small molecule designed to lengthen and protect telomeres-the protective DNA end caps of chromosomes that are crucial to cellular aging. As humans and animals age, telomeres naturally shorten, with metal reactivity accelerating this process, increasing the risk of degenerative and age-related diseases. By addressing the underlying causes of aging at the cellular level, Telomir aims to tackle the root of these conditions rather than simply treating their symptoms. Telomir is conducting ongoing preclinical research into Progeria, diabetes, cancer, Alzheimer's disease, osteoarthritis, and others.

Telomir Pharmaceuticals trades on the NASDAQ stock market under the symbol TELO.

As of January 2, 2026, TELO stock price declined to $1.32 with 21,313 million shares trading.

TELO has a beta of 1.42, meaning it tends to be more sensitive to market movements. TELO has a correlation of 0.06 to the broad based SPY ETF.

TELO has a market cap of $45.38 million. This is considered a Sub-Micro Cap stock.

The top ETF exchange traded funds that TELO belongs to (by Net Assets): VTI, VXF, IWC.

TELO has underperformed the market in the last year with a price return of -68.0% while the SPY ETF gained +18.4%. TELO has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -5.0% and -2.2%, respectively, while the SPY returned +3.4% and +2.6%, respectively.

TELO support price is $1.28 and resistance is $1.38 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TELO shares will trade within this expected range on the day.